Ocular Laboratory for Analysis of Biomarkers (OCULAB)
ID: ARPA-H-SOL-25-115Type: Solicitation
Overview

Buyer

HEALTH AND HUMAN SERVICES, DEPARTMENT OFNATIONAL INSTITUTES OF HEALTHNIH ADVANCED RESEARCH PROJECTS AGENCY FOR HEALTH (ARPA-H)Bethesda, MD, 208920004, USA

NAICS

Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) (541715)

PSC

HEALTH R&D SERVICES; HEALTH CARE SERVICES; EXPERIMENTAL DEVELOPMENT (AN13)
Timeline
    Description

    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) initiative. This program aims to develop innovative solutions for the diagnosis and treatment of ocular conditions, particularly focusing on dry eye disease (DED) through advanced biomarker analysis and therapeutic delivery systems. The initiative emphasizes the creation of a continuous monitoring biosensor integrated into a therapeutic device, leveraging artificial intelligence for non-invasive treatment methods, and encourages collaboration among commercial entities and academic institutions. Interested parties should contact the OCULAB Team at OCULAB@ARPA-H.gov for further details, with multiple awards anticipated as part of this funding opportunity, which is set to culminate with the final OCULAB Innovative Solutions Opening (ISO) on December 20, 2024.

    Point(s) of Contact
    Files
    Title
    Posted
    The document is a Solution Summary Template designed for submissions related to the OCULAB program under the ARPA-H-SOL-25-115 request for proposals. It outlines the required components for providing a comprehensive overview of proposed solutions, focusing on innovation and the potential impact of the project. The summary requires a succinct description of the technical concept, detailing the problems it addresses and how it surpasses current technologies. Key aspects include defining the project’s objectives, final deliverables, interim milestones, and technical strategies while also discussing alternative approaches and adoption challenges. Furthermore, the document emphasizes the importance of documenting project team roles, qualifications, and providing a rough order of magnitude for project costs. This structure ensures that all vital elements are presented clearly, enabling evaluators to assess the feasibility and potential of the proposed work effectively. The overall intent is to encourage innovative solutions that significantly advance industry capabilities and address technical challenges within the scope of the OCULAB initiative.
    This document provides a comprehensive overview of putative tear biomarkers associated with various systemic, neurological, and ocular diseases. It categorizes these biomarkers into three main disease classifications. For systemic diseases, biomarkers related to conditions such as cancer (breast, prostate, and other forms), COVID-19, diabetes, and Sjögren's syndrome are listed, highlighting proteins like S100A8, PSA, and IL-8. Neurological diseases focus on Alzheimer's, depression, Huntington's disease, migraines, and multiple sclerosis, featuring key biomarkers including Aβ, serotonin, and IgG oligoclonal bands. In the ocular disease category, biomarkers linked to conditions like diabetic retinopathy, glaucoma, keratoconus, and thyroid eye disease are detailed, indicating proteins such as BDNF, TNF-α, and VEGF. The structured approach reveals trends in biomarker identification across different diseases, which may aid in developing diagnostic and therapeutic strategies. This file is relevant to government RFPs and grants aimed at advancing medical research and improving healthcare outcomes related to these diseases. It highlights the critical need for innovative approaches in biomarker research that can influence funding priorities and inform collaborative initiatives in biomedical science.
    The document outlines the proposal format and instructions for submitting proposals under the ARPA-H OCULAB initiative, specifically referenced as ARPA-H-SOL-25-115. Proposers must use specified formats (PDF, ODX, DOC) and follow strict guidelines regarding content, organization, and presentation, including page limits and formatting constraints. The key sections of the proposal include an executive summary, goals and impact, a Gantt chart timeline, a technical plan, and risk mitigation strategies, along with optional components like a bibliography and letters of support. Proposers are instructed to focus on concise, clear, and innovative approaches while adhering to evaluation criteria. Additionally, the cost proposal section emphasizes the need for supporting documentation and compliance with federal salary caps. The goal is to ensure proposals are well-structured, innovative, and provide measurable outcomes that align with the initiative’s objectives.
    The Administrative and National Policy Requirements document stipulates essential guidelines for proposal submissions in response to government RFPs, particularly for the Advanced Research Projects Agency–Health (ARPA-H). Proposals must include a complete Administrative and National Policy Requirements document formatted for standard letter size, ensuring adequate margins and font sizes. Key sections include identification of team members, conflict of interest disclosures, federal assistance applications, and security disclosures pertinent to research personnel. Proposers are also required to disclose potential organizational conflicts of interest and report on any foreign participation impacting the proposal. Intellectual property claims must be detailed, along with any necessary disclosures related to patented inventions or software used in the project. Further requirements involve compliance with non-discrimination laws, animal care regulations for research, and adherence to cybersecurity protocols. Collectively, these elements ensure that submissions meet federal standards, affirm integrity in research practices, and protect sensitive information. This document serves as a comprehensive guide for entities seeking federal funding to structure their proposals in alignment with regulatory expectations.
    The Administrative and National Policy Requirements document is a critical component of the proposal submission process for federal RFPs and grants, requiring completion and inclusion with Volume 1 submissions. It outlines formatting requirements, including page size, margin specifications, and allowable font sizes. The document mandates the identification of team members, with clear distinctions regarding foreign participants and potential organizational conflicts of interest. It also incorporates essential disclosures related to research security, including potential conflicts of interest and prior governmental submissions for the proposed work. Further sections cover intellectual property considerations, compliance with human and animal subject research regulations, cybersecurity protocols, and representations regarding tax liabilities. The document emphasizes the need for adherence to government policies, highlighting responsibilities related to the management of Controlled Unclassified Information (CUI) and ethical research practices. Overall, the document provides a comprehensive framework to ensure transparency, security, and legal adherence in government-funded research proposals.
    The document outlines an Other Transaction Agreement between a specified Performer and the Advanced Research Projects Agency for Health (ARPA-H). It serves as a framework for a collaborative research project, detailing the agreement's scope, term, management, and administrative functions. Key articles cover obligations, payment structures, dispute resolution, and intellectual property rights. The Performer is expected to execute various technical tasks while adhering to specified reporting and milestone payment schedules. The agreement allows for mutual modification and establishes protocols for managing project disputes. Additionally, it emphasizes the need for compliance with federal laws, including those related to telecommunications and intellectual property. This structured agreement underscores the government's commitment to advancing health research and innovation through collaborative initiatives and rigorous oversight.
    The Advanced Research Projects Agency for Health (ARPA-H) has awarded a grant to [Institution Name] to support a specified project in line with federal statutes and regulations. The document outlines the award's financial details, including cumulative costs for salaries, materials, and administrative expenses, reassuring legal compliance and fiscal responsibility by the recipient. It establishes the roles of key personnel such as Grants Officers, Program Officials, and Principal Investigators, who are integral to managing and overseeing the grant's compliance and reporting requirements. Key terms include obligation for reporting executive compensation, adherence to civil rights laws, and ensuring funding is appropriately utilized and substantiated by financial audits. The document emphasizes transparency regarding subawards and necessitates compliance with federal regulations, including the Fly America Act and provisions against using restricted applications like TikTok. The recipient must also ensure proper acknowledgment of federal support in all project-related publications. The cooperative agreement underlines the government’s substantive involvement throughout the project. The recipient is expected to maintain a current registration in the System for Award Management (SAM.gov) and has the responsibility to report any violations pertaining to fraud or misconduct. Overall, this document serves to guide the recipient through the compliance landscape associated with their federal funding, ensuring accountability and transparency in the use of government resources.
    The Task Description Document (TDD) serves as a template for federal government proposals related to RFPs and grants, outlining the necessary components for detailing tasks and subtasks. It includes guidance on describing the objectives, methodologies, locations, responsible organizations, deliverables, potential human or animal research, and milestones for each task. The document emphasizes a structured breakdown of tasks, requiring a clear articulation of objectives and a defined approach to meet them. Each task must identify key milestones, which serve as measurable events indicating progress or completion. The TDD seeks to ensure all aspects of the proposed work are documented comprehensively, facilitating evaluation and oversight. This framework is critical for maintaining accountability and tracking outcomes within government-funded projects, as it allows for the assessment of various elements, including research involving human subjects or animals. The TDD’s structure aids in standardizing proposal submissions, thereby supporting efficient review processes at federal, state, and local levels, reflecting the streamlined operations required in governmental project management.
    The OCULAB (Ocular Laboratory for Analysis of Biomarkers) program, initiated by the Advanced Research Projects Agency for Health (ARPA-H), aims to enhance the diagnosis, monitoring, and treatment of ocular and systemic conditions, particularly dry eye disease (DED). This initiative encourages the development of advanced biosensor technology capable of continuous monitoring of tear biomarkers and AI-driven therapeutic delivery mechanisms. The program is structured into three phases over four years, emphasizing research on a biosensor housed in a minimally invasive device like a punctal plug and integration with cloud computing for real-time data analysis. Proposals must demonstrate innovation, capability, and collaboration between commercial and academic entities. Awards will be based on scientific merit and relevance to ARPA-H's mission, with an emphasis on diversity and accessibility in clinical trials and healthcare solutions. Multiple awards are anticipated, with a strong focus on the potential to revolutionize biomedical practices and improve patient care.
    The OCULAB initiative, under the Advanced Research Projects Agency for Health (ARPA-H), aims to revolutionize the diagnosis and treatment of ocular conditions, particularly dry eye disease (DED), through innovative biomarker analysis and therapeutic delivery systems. The program seeks proposals to develop a continuous monitoring biosensor integrated into a therapeutic device, utilizing AI for precise, non-invasive treatment methods. The platform incorporates a biosensor to measure tear biomarkers, facilitating real-time disease monitoring alongside a closed-loop system for drug delivery. This multi-phased program encourages diverse collaborations including commercial entities and academic institutions, with a focus on innovative technology that champions equitable healthcare access. Proposals are structured to include specific metrics for success, addressing challenges like patient medication compliance and the limitations of traditional blood testing. Proposals must conform to strict guidelines and undergo a merit-based evaluation process, with numerous awards expected to enhance the program's aims. Overall, OCULAB aspires to establish itself as a pioneering platform for ocular and systemic health, leveraging advancements in biosensor technology.
    The document is a notification regarding the need for Adobe Reader 8 or higher to view its content, which is pertinent to accessing government Requests for Proposals (RFPs), federal grants, and state/local RFPs. It clarifies that the user may either lack the required software or may need to properly configure their viewing environment for Adobe Reader. A link is provided for guidance on installation and configuration, ensuring that users can adequately access vital government forms and information. Overall, this communication emphasizes the significance of having the correct software setup to engage with federal and local funding opportunities effectively.
    The document outlines the procedures and requirements for preparing cost proposals in response to an ARPA-H solicitation. It emphasizes that unpriced options will not be accepted and that proposers must provide detailed costing for both Phase 1 and Phase 2 periods in specified tabs. Cost categories include direct labor, fringe benefits, and overhead, and proposers bear the responsibility of ensuring these costs are reasonable and well-supported. The document details the structure of the cost proposal spreadsheet, including essential tabs for labor rates, indirect costs, and specific task breakdowns, advising on data entry protocols. Key instructions highlight the need for accurate fiscal year details, the prohibition of profit on direct costs, and the required disclosures for subcontractors and consultants. The purpose is to facilitate a streamlined evaluation and negotiation process for funding proposals, underscoring the importance of clarity and precision in financial submissions to enhance compliance and expedite awards.
    The document is a Budget Justification for SF 424A, detailing the financial framework for a federal grant application submitted by an award recipient. It provides a structured overview of budget categories—Personnel, Fringe Benefits, Travel, Equipment, Supplies, Contractual Costs, and Indirect Charges—all currently valued at $0.00, indicating no costs have been projected for the proposed project. The instructions emphasize that all required fields must be filled out accurately, particularly for subrecipients whose contributions exceed 10% of the total project cost, requiring separate budget workbooks. The budget summary includes specifics on how costs must be justified according to federal guidelines, such as providing necessary rates, methodologies for estimations, and ensuring all costs align with the SF-424A. It also outlines the importance of maintaining compliance with regulations concerning indirect rates and cost principles. The structure consists of multiple sections, with detailed guidance for completing each component effectively. This document reflects standard procedures for federal funding applications, ensuring clarity and accountability in budgetary requests, ultimately aimed at supporting project execution and management effectively within federal frameworks.
    The document indicates an issue with accessing a specific file that requires Adobe Reader 8 or higher for proper viewing. It suggests that the viewer may lack the appropriate software installation or configuration required for PDF files. Users are directed to the Adobe website for assistance with installation and configuration. The purpose of the document is to inform users about technical requirements for accessing government-related documents, which may include important federal grants and RFPs. It underscores the need for proper technological support to ensure access to vital government resources.
    The document addresses technical issues with accessing a specific file that requires Adobe Reader 8 or higher for viewing. It states that the user may not have the necessary software installed or their environment configured properly to utilize Adobe Reader. Furthermore, it provides a URL directing users to Adobe's site for installation and configuration assistance. The purpose of the document is to guide users in resolving access issues related to government documents, particularly those related to RFPs, grants, and other federal or state communications. This highlights the importance of having the proper tools at hand to access essential government information efficiently.
    The document discusses accessibility issues related to viewing a government file, specifically indicating that Adobe Reader 8 or higher is required for proper access. It suggests that the user may not have the necessary software installed or their environment is not configured correctly to utilize Adobe Reader. The document directs users to a webpage providing guidance on how to install Adobe Reader and configure their systems for compatibility. This highlights the importance of accessibility in government documentation, ensuring that individuals can successfully access crucial information related to federal grants, RFPs, and the broader context of public procurement. However, due to the technical nature of the content, there are no explicit details regarding the specific RFPs or grants themselves.
    The document discusses the need for Adobe Reader to view a specific federal government file related to RFPs, federal grants, and state/local RFPs. It outlines potential issues users might face if they do not have the required version of Adobe Reader installed or if the viewing environment is not properly configured. The file's accessibility is crucial for reviewing significant government documents, suggesting that a lack of proper software could hinder access to important information. Users are directed to a link for guidance on installing and configuring Adobe Reader, highlighting the importance of having the appropriate tools to engage with government resources efficiently. Overall, the document emphasizes technical requirements necessary for accessing federal documentation effectively.
    The document indicates that there is a technical issue preventing access to the government file, specifically requiring Adobe Reader 8 or higher for proper viewing. It suggests that the user may not have the necessary software installed or that their viewing environment is not configured to support Adobe Reader. To resolve this issue, the document provides a link to Adobe's website for guidance on installation and environment configuration. This information is crucial for users looking to access federal RFPs, grants, or local solicitation documents as it emphasizes the need for correct software to view sensitive and potentially time-sensitive government information. The inability to access these documents can impede the application process for grants and RFPs, underscoring the importance of proper software readiness in engaging with government resources.
    The document addresses the technical requirements for accessing an unspecified file, indicating that Adobe Reader 8 or higher is necessary for proper viewing. It notes potential issues users may encounter if Adobe Reader is not installed or if their environment is not configured correctly to use the software. The document provides a link for users to find more information on installing Adobe Reader and configuring their system for PDF forms. While the file does not contain substantive content related to federal RFPs, grants, or local RFPs, it emphasizes the importance of having the appropriate software setup to access potentially crucial government-related documentation. The necessity for proper software highlights the broader context of ensuring efficient communication and access to government resources.
    The provided file indicates an issue with accessing a document that requires Adobe Reader 8 or higher. Users may not be able to view the document due to the absence of the necessary software or improper configuration of their viewing environment. It advises on how to install Adobe Reader and adjust viewing settings, directing users to the Adobe website for assistance. This technical notice is relevant for individuals attempting to access government files related to federal grants, RFPs, and state/local proposals, emphasizing the importance of having the correct tools for accessing electronic documents in government proceedings.
    Lifecycle
    Title
    Type
    Similar Opportunities
    Ocular Laboratory for Analysis of Biomarkers (OCULAB)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is announcing a Proposers' Day for the Ocular Laboratory for Analysis of Biomarkers (OCULAB) program. This initiative aims to develop non-invasive diagnostic technologies for ocular and systemic conditions, particularly focusing on dry eye disease, through two primary technical areas: sensor technology for continuous biomarker monitoring and closed-loop therapeutic dosing systems. The Proposers' Day, scheduled for December 12, 2024, in Tampa Bay, Florida, will facilitate collaboration among participants and provide insights into the program's goals, with registration open from October 18, 2024, to December 5, 2024. Interested parties can contact OCULAB@ARPA-H.gov for further information and are encouraged to register for the event to enhance their proposal submissions.
    Office-Wide Innovative Solutions Opening for Health Science Futures (HSF)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Innovative Solutions Opening (ISO) aimed at advancing healthcare technologies. This initiative seeks innovative, disease-agnostic research projects that can significantly improve health outcomes, focusing on areas such as maternal and fetal health, genetic therapies, and novel diagnostic tools. The solicitation emphasizes the development of transformative solutions rather than incremental research, with submissions required to follow a two-step process: an initial solution summary followed by a full proposal based on feedback received. Interested parties must submit their solution summaries by March 3, 2029, via the designated ARPA-H portal, and are encouraged to review the detailed submission guidelines outlined in the provided documentation.
    Office-Wide Innovative Solutions Opening for Proactive Health Office (PHO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative research proposals aimed at enhancing health outcomes via the Proactive Health Office (PHO). The initiative focuses on developing solutions that prioritize disease prevention, early intervention, and scalable wellness-promoting behaviors, moving away from traditional reactive healthcare models. This opportunity is significant for entities capable of delivering transformative health solutions, with proposals evaluated based on scientific merit and relevance, and funding potentially awarded through Other Transactions or Cooperative Agreements. Interested parties must submit a mandatory solution summary by March 3, 2029, and can direct inquiries to the designated contact via the provided submission platforms.
    In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health (NIH), is seeking innovative proposals for the development of In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems. The initiative aims to address the challenges posed by light scattering in biological tissues, which currently limits the effectiveness of non-invasive optical imaging techniques in assessing tissue function and structure. This funding opportunity encourages the advancement of next-generation imaging technologies that can achieve deeper penetration and higher resolution in biological systems. Interested applicants should note that the application due date is March 7, 2025, by 5:00 PM local time, and are encouraged to submit a letter of intent by the same date. For further inquiries, contact Jonathan Pollock at jpollock@mail.nih.gov or Robert Bailey at rob.bailey@nih.gov.
    Office-Wide Innovative Solutions Opening for Scalable Solutions Office (SSO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing healthcare accessibility, affordability, and scalability. This opportunity invites universities, non-profits, small businesses, and similar entities to submit solution summaries and proposals that address health disparities, improve the distribution of healthcare technologies, and advance biomanufacturing innovations. The solicitation emphasizes the development of scalable technologies and collaborative distribution networks, with a focus on interdisciplinary approaches to revolutionize biomedicine and public health outcomes. Interested parties must submit their solution summaries by March 3, 2029, and can find further details and submission guidelines at https://solutions.arpa-h.gov. For inquiries, questions should be directed to the same website.
    Office-Wide Innovative Solutions Opening for Resilient Systems Office (RSO)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting innovative solutions aimed at enhancing the resilience of healthcare systems via its Resilient Systems Office (RSO). This opportunity invites submissions from eligible entities, including universities, nonprofits, and small businesses, to address systemic challenges in healthcare and public health by leveraging cutting-edge technologies that improve care quality and availability. The solicitation emphasizes the importance of sociotechnical system innovations and adaptive solutions that enhance the reliability and interoperability of health ecosystems. Interested parties must submit solution summaries for feedback before full proposal submissions, with the solicitation open until March 3, 2029. For further inquiries, submissions should be directed to the designated online platforms, and the primary contact email is provided in the solicitation details.
    POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in ONcology)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the POSEIDON program, which aims to develop synthetic-biology-based Multi-Cancer Early Detection (MCED) tests for over 30 solid tumors. The program's objectives include creating non-invasive detection methods utilizing breath and urine samples, with a focus on improving accessibility and reducing late-stage cancer diagnoses, particularly among underserved populations. Proposers must form multidisciplinary teams and submit comprehensive proposals that include a commercialization plan, with full proposals due by January 22, 2025, at 5:00 PM EST. Interested parties can direct inquiries to the POSEIDON Team at POSEIDON@arpa-h.gov.
    ARPA-H ImagiNg Data EXchange (INDEX)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Imaging Data Exchange (INDEX) Program. This initiative aims to establish a sustainable platform that connects medical imaging data providers with developers and researchers, leveraging artificial intelligence and machine learning to enhance access to diverse medical imaging data and improve healthcare outcomes. The program is structured in two phases, focusing on business model refinement and system architecture design, with an emphasis on participant engagement and data quality. Interested parties can reach out to the INDEX Team at INDEX@arpa-h.gov for further information, and they are encouraged to review the attached Draft INDEX Innovative Solutions Opening (ISO) ARPA-H-SOL-25-112 for detailed requirements.
    Performance and Reliability Evaluation for Continuous modIfications and uSEability of AI (PRECISE-AI)
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, through the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is soliciting proposals for the Performance and Reliability Evaluation for Continuous modifications and Usability of AI (PRECISE-AI) program. This initiative aims to develop self-correction techniques to ensure the ongoing safety and efficacy of artificial intelligence (AI) systems in healthcare, particularly focusing on AI Decision Support Tools (AI-DSTs) that are increasingly utilized in clinical settings. The program seeks to address the critical need for continuous monitoring and updating of AI models to enhance clinician decision-making and improve patient outcomes, with a structured proposal submission process that includes detailed technical and management plans. Interested parties can contact the PRECISE-AI Coordinator at PRECISEAI@arpa-h.gov for further information, with proposals due as specified in the solicitation documents.
    Emerging Health Innovators (EHI) Initiative Proposers' Day
    Active
    Health And Human Services, Department Of
    The Department of Health and Human Services, specifically the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H), is hosting a virtual Proposers' Day for the Emerging Health Innovators (EHI) Initiative on January 8, 2025. This initiative aims to engage early career investigators and community innovators in advanced health research, with two application tracks: Technology-Driven Innovation for biomedical researchers and Community-Centered Innovation for community innovators, each focusing on innovative health technologies and community health solutions. Proposals may receive funding of up to $350,000 annually for two years, with a potential extension, and interested participants should register by January 6, 2025, to gain insights into funding opportunities and submission guidelines. For further information, potential proposers can contact the EHI Initiative Team at EHI@ARPA-H.gov.